Powered by Blogger.

Blog Archive

Friday, December 20, 2013

By Robert Sutter


Brain cancer research is going to focus tremendously on glioblastoma and for all of the right reasons. It is one of the most important names to consider when it comes to this particular field, which is something that you can figure out in due time. Seeing as how treatment may be troublesome to find, though, what if I were to tell you that a tandem of drugs can bring about certain degrees of success? I believe that it is a point to take into consideration when considering such a serious ailment.

US News and World Report put up a written piece that spoke about the idea of treatment in terms of glioblastoma. It seems to be one of the greatest goals that is being worked to, which is especially true when considering how common - not to mention aggressive - this particular growth can be. The University of Zurich stated that the condition, at this point, is "virtually incurable." However, it seems as though a unique drug therapy could potentially prove to be one of the most useful in the long term.

The study group put together a procedure that would be able to target the tumors that were seen in mice. They were simultaneously injected with a T cell-boosting protein referred to as interleukin-12, as well as another drug that would serve to block an inhibitory function within the T cell. In spite of only IL-12 being put to use, there was an increased survival rate in mice by 25%. While this is a notable result to consider, is it possible that it can only stop at this point?

I believe that this is a particular case that will be able to benefit the ongoings that are associated with brain cancer research. Another drug would be able to come into play, making sure that the T cells could not regulate like they would have normally. The survival rate, in turn, changed from 25% and boosted to a much higher 80%. To say that this type of increase is tremendous would be an understatement and I'd like to think that many organizations would be able to focus on it, V-A-B-C seen amongst them.

No matter where the results of the study go, I do not think that anyone can argue with the fact that possibilities are going to be focused on in great detail. Brain cancer research is all about finding out what is going to work best in the long term, which is something that should go without saying. Sometimes, though, researchers have to be able to find more unique combinations that have potential healing properties. This story, in my opinion, is one that can bring even greater results about in due time.




About the Author:



0 comments:

Post a Comment